|
Market Closed -
OTC Markets
23:46:37 25/09/2026 +04
|
5-day change | 1st Jan Change | ||
| 0.000001 USD | 0.00% |
|
0.00% | - |
| Market Cap | 3.91M 2.76M 2.43M 2.3M 2.08M 265M 3.93M 27.49M 10.62M 135M 10.37M 10.14M 435M | P/E 2018 |
-4.94x | P/E 2019 | -0.37x |
|---|---|---|---|---|---|
| Enterprise Value | 9.13M 6.45M 5.67M 5.36M 4.86M 619M 9.19M 64.2M 24.79M 316M 24.21M 23.68M 1.01B | EV / Sales 2018 |
12.6x | EV / Sales 2019 | 2.48x |
| Free-Float |
100% | Yield 2018 * |
-
| Yield 2019 | - |
| 1 week | 0 |  | 0 |
| 1 month | 0 | | 0 |
| Current year | 0 | | 0 |
| 1 year | 0 | | 0 |
| 3 years | 0 | | 0 |
| 5 years | 0 | | 0.29 |
| 10 years | 0 | | 16.9 |
| Manager | Title | Age | Since |
|---|---|---|---|
Marcos Agramont
CEO | Chief Executive Officer | - | 24/05/2017 |
Andrew Alvis
DFI | Director of Finance/CFO | - | - |
| Corporate Officer/Principal | - | 30/08/2018 |
| Director | Title | Age | Since |
|---|---|---|---|
Marcos Agramont
BRD | Director/Board Member | - | 24/05/2017 |
| Director/Board Member | - | 30/08/2018 | |
| Director/Board Member | - | 21/11/2018 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 0.00% | 0.00% | - | - | 128 | |
| +0.92% | -1.49% | -11.87% | -5.57% | 13.38B | |
| -0.04% | -1.39% | -31.78% | -57.41% | 4.77B | |
| +0.29% | -0.70% | -4.83% | -7.70% | 4.3B | |
| +0.07% | -2.82% | -4.17% | -35.42% | 3.77B | |
| +0.14% | -0.06% | -19.70% | -3.43% | 3.49B | |
| +1.02% | -1.20% | -0.88% | -9.80% | 3.39B | |
| +0.88% | -1.92% | -12.16% | -4.96% | 3.07B | |
| -0.34% | -2.03% | -20.76% | -19.25% | 2.24B | |
| -0.46% | -3.07% | -25.72% | -25.92% | 1.63B | |
| Average | +0.25% | -1.47% | -14.65% | -18.83% | 4B | |
| Weighted average by Cap. | +0.47% | -1.50% | -13.60% | -16.50% |
| 2018 | 2019 | |
|---|---|---|
| Net sales | 19.14M 13.51M 11.88M 11.23M 10.19M 1.3B 19.25M 135M 51.95M 662M 50.72M 49.62M 2.13B | 22.25M 15.7M 13.81M 13.06M 11.85M 1.51B 22.38M 156M 60.4M 769M 58.96M 57.68M 2.47B |
| Net income | -36.02M -25.43M -22.36M -21.15M -19.18M -2.44B -36.23M -253M -97.78M -1.25B -95.46M -93.39M -4B | -126M -88.88M -78.17M -73.92M -67.05M -8.53B -127M -885M -342M -4.35B -334M -326M -13.99B |
| Net Debt | -15.55M -10.98M -9.65M -9.13M -8.28M -1.05B -15.64M -109M -42.21M -538M -41.21M -40.32M -1.73B | 5.22M 3.69M 3.24M 3.07M 2.78M 354M 5.25M 36.71M 14.18M 181M 13.84M 13.54M 580M |
Employees
-
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 25/09/26 | $0.000001 | 0.00% | 2,000 |
- Stock Market
- Stocks
- ISOLF Stock
Select your edition
All financial news and data tailored to specific country editions
